Uploading Your EHR Voids HIPAA: Six Laws Fill the Gap
The moment a patient uploads their medical record to your AI health platform, HIPAA protection evaporates.
The moment a patient uploads their medical record to your AI health platform, HIPAA protection evaporates.
BeOne Medicines is paying $20 million upfront to reserve an exclusive option on HH160, a preclinical trispecific antibody from Beijing-based Huahui Health.
AbbVie pulled in $15 billion in Q1 revenue, beating consensus estimates and raising its full-year guidance.
Ukrainian cyber police, Lviv regional prosecutors, and the Security Service of Ukraine arrested three men on charges under Ukraine's Criminal Code Article…
OppFi paid $130 million for BNCCORP and its BNC National Bank subsidiary, a cash-and-stock deal that values the Glendale, Arizona lender at 1.2 times its…
Adyen paid €750 million ($876 million) in cash to buy Talon.
Eli Lilly struck deals worth up to $11.55 billion across three acquisitions in two weeks: an up-to-$2.25 billion pact with AI biotech Profluent for genetic…
Canada's 2026 Spring Economic Update, released Tuesday, proposes banning crypto ATMs nationwide.
AstraZeneca posted $15.3 billion in first-quarter sales, led by Enhertu and Imfinzi, clearing the $14.7 billion analyst consensus and reinforcing CEO Pascal…
Chiesi paid roughly $1.9 billion to buy KalVista Pharmaceuticals, an Italian pharma adding a commercial-stage biotech to its portfolio.
DOJ charged Abraham Cigarroa Cervantes, former finance director of Stericycle's Latin America division, with two counts of conspiracy under the Foreign…
FDA is launching a pilot program to collect and review clinical trial data in real time, giving scientific reviewers direct access to trial results as they…
ShinyHunters claims it breached Udemy, one of the world's largest online learning platforms, and is threatening to publish 1.4 million customer and…
ShinyHunters, the extortion group behind a wave of Snowflake-linked breaches, has put Vimeo on a clock: pay up or face a public data dump by April 30.
AbbVie has secured an exclusive right to buy Kestrel Therapeutics for up to $1.45 billion, with the biotech required to hit unspecified development and…